Added to YB: 2018-11-21
Pitch date: 2018-11-21
DBVT [bullish]
DBV Technologies S.A.
-88.57%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
Market Cap
EUR 455.4M
Pitch Price
EUR 27.34
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.15
P/E
-2.55
EV/Sales
71.47
Sector
Biotechnology
Category
N/A
Show full summary:
DBV TECHNOLOGIES DBVT
A summary for this pitch has not been created yet.
Read full article (0 min)